The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Papillary Thyroid Cancer: Genetic Alterations and Molecular Biomarker Investigations
Open accessAbstract
Papillary thyroid cancer (PTC) is the most prevalent form of malignancy among all cancers of the thyroid. It is also one of the few cancers with a rapidly increasing incidence. PTC is usually contained within the thyroid gland and generally biologically indolent. Prognosis of the cancer is excellent, with less than 2% mortality at 5 years. However, more than 25% of patients with PTC developed a recurrence during a long term follow-up. The present article provides an updated condensed overview of PTC, which focuses mainly on the molecular alterations involved and recent biomarker investigations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Increasing Incidence of Thyroid Cancer in the United States, 1973-2002
Davies, L., & Welch, H. G. (2006) · JAMA · doi:10.1001/jama.295.18.2164 · Cited by 3,369
Papini, E., Guglielmi, R., Bianchini, A., Crescenzi, A., Taccogna, S., Nardi, F., Panunzi, C., Rinaldi, R., Toscano, V., & Pacella, C. M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.5.1941 · Cited by 1,441
BRAF mutation in thyroid cancer
Xing, M. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.0978 · Cited by 1,300
The role of microRNA genes in papillary thyroid carcinoma
He, H., Jazdzewski, K., Li, W., Liyanarachchi, S., Nagy, R., Volinia, S., Calin, G. A., Liu, C.-G., Franssila, K., Suster, S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509603102 · Cited by 1,215
MicroRNA in Control of Gene Expression: An Overview of Nuclear Functions
Catalanotto, C., Cogoni, C., & Zardo, G. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17101712 · Cited by 1,190
Lin, J. S., Bowles, E. J. A., Williams, S. B., & Morrison, C. C. (2017) · JAMA · doi:10.1001/jama.2017.0562 · Cited by 1,082
Characterization of a multicomponent receptor for GDNF
Treanor, J. J. S., Goodman, L., de Sauvage, F., Stone, D. M., Poulsen, K. T., Beck, C. D., Gray, C., Armanini, M. P., Pollock, R. A., Hefti, F., et al. (1996) · Nature · doi:10.1038/382080a0 · Cited by 1,080
Molecular genetics and diagnosis of thyroid cancer
Nikiforov, Y. E., & Nikiforova, M. N. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.142 · Cited by 1,011
Nikiforov, Y. E., Rowland, J. M., Bove, K. E., Monforte-Muñoz, H., & Fagin, J. A. (1997) · PubMed · Cited by 666
Haigis, K. M., Kendall, K. R., Wang, Y., Cheung, A., Haigis, M. C., Glickman, J. N., Niwa-Kawakita, M., Sweet-Cordero, A., Sebolt-Leopold, J., Shannon, K. M., et al. (2008) · Nature Genetics · doi:10.1038/ng.115 · Cited by 610
MicroRNA Expression Profiling of Thyroid Tumors: Biological Significance and Diagnostic Utility
Nikiforova, M. N., Tseng, G. C., Steward, D., Diorio, D., & Nikiforov, Y. E. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2696 · Cited by 582
MicroRNA deregulation in human thyroid papillary carcinomas
Pallante, P., Visone, R., Ferracin, M., Ferraro, A., Berlingieri, M. T., Troncone, G., Chiappetta, G., Liu, C. G., Santoro, M., Negrini, M., et al. (2006) · Endocrine-Related Cancer · doi:10.1677/erc.1.01209 · Cited by 527
Association Between BRAF V600E Mutation and Recurrence of Papillary Thyroid Cancer
Xing, M., Alzahrani, A. S., Carson, K. A., Shong, Y. K., Kim, T. Y., Viola, D., Elisei, R., Bendlová, B., Yip, L., Mian, C., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.56.8253 · Cited by 523
Belfiore, A., Rosa, G. L. L., Porta, G. A. L., Giuffrida, D., Milazzo, G., Lupo, L., Regalbuto, C., & Vigneri, R. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90164-7 · Cited by 516
Observer Variation in the Diagnosis of Follicular Variant of Papillary Thyroid Carcinoma
Lloyd, R. V., Erickson, L. A., Casey, M. B., Lam, K. Y., Lohse, C. M., Asa, S. L., Chan, J. K. C., DeLellis, R. A., Harach, H. R., Kakudo, K., et al. (2004) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000135519.34847.f6 · Cited by 498
Adeniran, A. J., Zhu, Z., Gandhi, M., Steward, D. L., Fidler, J. P., Giordano, T. J., Biddinger, P. W., & Nikiforov, Y. E. (2006) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000176432.73455.1b · Cited by 495
RET/PTC Rearrangement in Thyroid Tumors
Nikiforov, Y. E. (2002) · Endocrine Pathology · doi:10.1385/ep:13:1:03 · Cited by 489
Gene expression in papillary thyroid carcinoma reveals highly consistent profiles
Huang, Y., Prasad, M., Lemon, W. J., Hampel, H., Wright, F. A., Kornacker, K., LiVolsi, V., Frankel, W., Kloos, R. T., Eng, C., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251547398 · Cited by 442
A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases
Fusco, A., Grieco, M., Santoro, M., Berlingieri, M. T., Pilotti, S., Pierotti, M. A., Porta, G. D., & Vecchio, G. (1987) · Nature · doi:10.1038/328170a0 · Cited by 413
Londin, E., Loher, P., Telonis, A. G., Quann, K., Clark, P., Jing, Y., Hatzimichael, E., Kirino, Y., Honda, S., Lally, M., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1420955112 · Cited by 404
Giordano, T. J., Kuick, R., Thomas, D. G., Misek, D. E., Vinco, M., Sanders, D., Zhu, Z., Ciampi, R., Roh, M., Shedden, K., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208822 · Cited by 383
An Overview of the Management of Papillary and Follicular Thyroid Carcinoma
MAZZAFERRI, E. L. (1999) · Thyroid · doi:10.1089/thy.1999.9.421 · Cited by 368
BRAF mutations are associated with some histological types of papillary thyroid carcinoma
Trovisco, V., Vieira de Castro, I., Soares, P., Máximo, V., Silva, P., Magalhães, J., Abrosimov, A., Guiu, X. M., & Sobrinho‐Simões, M. (2004) · The Journal of Pathology · doi:10.1002/path.1511 · Cited by 363
Papillary thyroid carcinoma: an update
LiVolsi, V. A. (2011) · Modern Pathology · doi:10.1038/modpathol.2010.129 · Cited by 353
Elsheikh, T. M., Asa, S. L., Chan, J. K. C., DeLellis, R. A., Heffess, C. S., LiVolsi, V. A., & Wenig, B. M. (2008) · American Journal of Clinical Pathology · doi:10.1309/ajcpkp2quvn4rccp · Cited by 320
Communication Gap with Oncologists, Not Cost, Tops Patients' Value Priorities.
Nguyen, Q. T., Lee, E. J., Huang, M., Park, Y. I., Khullar, A., & Plodkowski, R. A. (2015) · Europe PMC (PubMed Central) · Cited by 314
Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas
Jhiang, S. M. (1996) · Endocrinology · doi:10.1210/en.137.1.375 · Cited by 314
A study of recurrence and death from papillary thyroid cancer with 27 years of median follow-up
Grogan, R. H., Kaplan, S. P., Cao, H., Weiss, R. E., DeGroot, L. J., Simon, C. A., Embia, O. M. A., Angelos, P., Kaplan, E. L., & Schechter, R. B. (2013) · Surgery · doi:10.1016/j.surg.2013.07.008 · Cited by 301
Lee, J., Lee, E., & Kim, Y. (2007) · Cancer · doi:10.1002/cncr.22754 · Cited by 291
Papillary Thyroid Carcinoma Variants
Lloyd, R. V., Buehler, D., & Khanafshar, E. (2011) · Head and Neck Pathology · doi:10.1007/s12105-010-0236-9 · Cited by 277
Li, C., Lee, K. C., Schneider, E. B., & Zeiger, M. A. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2104 · Cited by 275
Radiation exposure and thyroid cancer: a review
Iglesias, M. L., Schmidt, A., Ghuzlan, A. A., Lacroix, L., Vathaire, F. D., Chevillard, S., & Schlumberger, M. (2017) · Archives of Endocrinology and Metabolism · doi:10.1590/2359-3997000000257 · Cited by 243
Activated ras oncogenes in human thyroid cancers.
Lemoine, N. R., Mayall, E. S., Wyllie, F. S., Farr, C. J., Hughes, D., Padua, R. A., Thurston, V., Williams, E. D., & Wynford‐Thomas, D. (1988) · PubMed · Cited by 233
Circulating MicroRNA Profiles as Potential Biomarkers for Diagnosis of Papillary Thyroid Carcinoma
Yu, S., Liu, Y., Wang, J., Guo, Z., Zhang, Q., Yu, F., Zhang, Y., Huang, K., Li, Y., Song, E., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3059 · Cited by 207
Increasing Incidence of Thyroid Cancer in the United States, 1973–2002
Fahey, T. J. (2007) · Yearbook of Surgery · doi:10.1016/s0090-3671(08)70112-5 · Cited by 195
Mazzaferri, E. L., & Massoll, N. (2002) · Endocrine-related cancer · doi:10.1677/erc.0.0090227 · Cited by 182
Evaluation of a Thyroid Nodule
Bomeli, S. R., LeBeau, S. O., & Ferris, R. L. (2010) · Otolaryngologic Clinics of North America · doi:10.1016/j.otc.2010.01.002 · Cited by 181
Knauf, J. A., Kuroda, H., Basu, S., & Fagin, J. A. (2003) · Oncogene · doi:10.1038/sj.onc.1206602 · Cited by 181
RET/PTC Translocations and Clinico-Pathological Features in Human Papillary Thyroid Carcinoma
Romei, C., & Elisei, R. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00054 · Cited by 176
Molecular pathology of thyroid cancer: diagnostic and clinical implications
Fagin, J. A., & Mitsiades, N. (2008) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.09.017 · Cited by 167
Lee, J. C., Zhao, J. T., Clifton‐Bligh, R. J., Gill, A., Gundara, J. S., Ip, J. C., Glover, A., Sywak, M. S., Delbridge, L. W., Robinson, B. G., et al. (2013) · Cancer · doi:10.1002/cncr.28254 · Cited by 163
Wasenius, V.-M., Hemmer, S., Kettunen, E., Knuutila, S., Franssila, K., & Joensuu, H. (2003) · PubMed · Cited by 163
Thyroid Cancer in Patients with Hyperthyroidism
Pazaitou‐Panayiotou, K., Michalakis, K. G., & Paschke, R. (2012) · Hormone and Metabolic Research · doi:10.1055/s-0031-1299741 · Cited by 146
Sugg, S. L., Zheng, L., Rosen, I. B., Freeman, J. L., Ezzat, S., & Asa, S. L. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.9.8784097 · Cited by 146
Molecular Profiling Distinguishes Papillary Carcinoma from Benign Thyroid Nodules
Finley, D. J., Arora, N., Zhu, B., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031811 · Cited by 141
de la Chapelle, A., & Jażdżewski, K. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1004 · Cited by 131
RAS proto-oncogene in medullary thyroid carcinoma
Moura, M. M., Cavaco, B. M., & Leite, V. A. P. H. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0070 · Cited by 114
Fine-Needle Aspiration of Thyroid Nodules: Proteomic Analysis To Identify Cancer Biomarkers
Giusti, L., Iacconi, P., Ciregia, F., Giannaccini, G., Donatini, G. L., Basolo, F., Miccoli, P., Pinchera, A., & Lucacchini, A. (2008) · Journal of Proteome Research · doi:10.1021/pr8000404 · Cited by 111
Oler, G., Camacho, C. P., Hojaij, F. C., Michaluart, P., Riggins, G. J., & Cerutti, J. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4372 · Cited by 102
miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma
Minna, E., Romeo, P., Dugo, M., Cecco, L. D., Todoerti, K., Pilotti, S., Perrone, F., Seregni, E. C., Agnelli, L., Neri, A., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7262 · Cited by 102
MicroRNAs as Biomarkers in Thyroid Carcinoma
Celano, M., Rosignolo, F., Maggisano, V., Pecce, V., Iannone, M., Russo, D., & Bulotta, S. (2017) · International Journal of Genomics · doi:10.1155/2017/6496570 · Cited by 101
Paulson, V., Shivdasani, P., Angell, T. E., Cibas, E. S., Krane, J. F., Lindeman, N. I., Alexander, E. K., & Barletta, J. A. (2017) · Thyroid · doi:10.1089/thy.2016.0583 · Cited by 96
Discovery and identification of potential biomarkers of papillary thyroid carcinoma
Fan, Y., Shi, L., Liu, Q., Dong, R., Zhang, Q., Yang, S., Fan, Y., Yang, H., Wu, P., Yu, J., et al. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-79 · Cited by 85
6: Thyroid nodules and thyroid cancer
Mackenzie, E. J., & Mortimer, R. H. (2004) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2004.tb05894.x · Cited by 84
Cancer after Thyroidectomy: A Multi-Institutional Experience with 1,523 Patients
Smith, J. J., Chen, X., Schneider, D. F., Broome, J. T., Sippel, R. S., Chen, H., & Solórzano, C. C. (2013) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2012.12.022 · Cited by 83
MicroRNA-146b: A Novel Biomarker and Therapeutic Target for Human Papillary Thyroid Cancer
Chou, C., Liu, R., & Kang, H. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030636 · Cited by 83
MicroRNA-based molecular classification of papillary thyroid carcinoma
Rosignolo, F., Memeo, L., Monzani, F., Colarossi, C., Pecce, V., Verrienti, A., Durante, C., Grani, G., Lamartina, L., Forte, S., et al. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.3960 · Cited by 81
The Evolution of Biomarkers in Thyroid Cancer—From Mass Screening to a Personalized Biosignature
Grogan, R. H., Mitmaker, E. J., & Clark, O. H. (2010) · Cancers · doi:10.3390/cancers2020885 · Cited by 79
Microarray Analysis of Papillary Thyroid Cancers in Korean
Kim, H. S., Kim, D. H., Kim, J. Y., Jeoung, N. H., Lee, I. K., Bong, J. G., & Jung, E. D. (2010) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2010.25.4.399 · Cited by 73
Fujarewicz, K., Jarząb, M., Eszlinger, M., et al. (2007) · Endocrine Related Cancer · doi:10.1677/erc-06-0048 · Cited by 73
Li, M., Song, Q., Li, H., Lou, Y., & Wang, L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132403 · Cited by 67
Hawthorn, L., Stein, L. C., Varma, R., Wiseman, S., Loree, T. R., & Tan, D. (2004) · Head & Neck · doi:10.1002/hed.20099 · Cited by 66
Rusinek, D., Świerniak, M., Chmielik, E., Kowal, M., Kowalska, M., Cyplinska, R., Czarniecka, A., Pigłowski, W., Korfanty, J., Chekan, M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143688 · Cited by 63
Can the Acute-Phase Reactant Proteins be Used as Cancer Biomarkers?
Pang, W. W., Abdul‐Rahman, P. S., Wan‐Ibrahim, W. I., & Hashim, O. H. (2010) · The International Journal of Biological Markers · doi:10.1177/172460081002500101 · Cited by 60
Self-citationYano, Y., Uematsu, N., Yashiro, T., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0807-03 · Cited by 58
Martínez‐Aguilar, J., Clifton-Bligh, R. J., & Molloy, M. P. (2016) · Scientific Reports · doi:10.1038/srep23660 · Cited by 57
Serum microRNA profiling to distinguish papillary thyroid cancer from benign thyroid masses
Graham, M. E., Hart, R. D., Douglas, S. E., Makki, F. M., Pinto, D. M., Butler, A. L., Bullock, M. J., Rigby, M. H., Trites, J. R. B., Taylor, S. M., et al. (2015) · Journal of Otolaryngology - Head and Neck Surgery · doi:10.1186/s40463-015-0083-5 · Cited by 56
Proteomic Identification of New Biomarkers and Application in Thyroid Cytology
Torres-Cabala, C. A., Bibbo, M., Panizo-Santos, Á., Barazi, H., Krutzsch, H. C., Roberts, D. D., & Merino, M. J. (2006) · Acta Cytologica · doi:10.1159/000326006 · Cited by 49
Vierlinger, K., Mansfeld, M., Koperek, O., Nöhammer, C., Kaserer, K., & Leisch, F. (2011) · BMC Medical Genomics · doi:10.1186/1755-8794-4-30 · Cited by 46
CXCL12 methylation-mediated epigenetic regulation of gene expression in papillary thyroid carcinoma
Zhang, S., Wang, Y., Chen, M., Sun, L., Han, J., Elena, V.-N., & Qiao, H. (2017) · Scientific Reports · doi:10.1038/srep44033 · Cited by 43
Maia, F. F. R., & Zantut‐Wittmann, D. E. (2012) · Clinics · doi:10.6061/clinics/2012(08)15 · Cited by 40
Qu, T., Li, Y., Li, X.-H., & Chen, Y. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5855 · Cited by 39
Sofiadis, A., Dinets, A., Orre, L. M., Branca, R. M., Juhlin, C. C., Foukakis, T., Wallin, G., Höög, A., Hulchiy, M., Zedenius, J., et al. (2010) · Thyroid · doi:10.1089/thy.2009.0400 · Cited by 37
Paricharttanakul, N. M., Saharat, K., Chokchaichamnankit, D., Punyarit, P., Srisomsap, C., & Svasti, J. (2016) · Oncology Reports · doi:10.3892/or.2016.4567 · Cited by 37
Decreased annexin A3 expression correlates with tumor progression in papillary thyroid cancer
Jung, E., Moon, H., Park, S., Cho, B.-I., Lee, S., Jeong, C., Ju, Y., Jeong, S., Lee, Y., Choi, S., et al. (2010) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200900063 · Cited by 36
Trends in thyroid cancer incidence and mortality in Portugal
Raposo, L., Morais, S., Oliveira, M. J., Marques, A., Bento, M. J., & Lunet, N. (2016) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000229 · Cited by 34
Vesco, K. K., Whitlock, E. P., Eder, M. L., et al. (2017) · Cited by 28
Yu, S., Liu, X., Zhang, Y., Li, J., Chen, S., Zheng, H., Reng, R., Zhang, C., Chen, J., & Chen, L. (2016) · Oncotarget · doi:10.18632/oncotarget.12389 · Cited by 28
Dinets, A., Pernemalm, M., Kjellin, H., Sviatoha, V., Sofiadis, A., Juhlin, C. C., Zedenius, J., Larsson, C., Lehtiö, J., & Höög, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126472 · Cited by 26
Incidental cancer in multinodular goitre post thyroidectomy.
Bombil, I., Bentley, A., Kruger, D., & Luvhengo, T. E. (2014) · PubMed · Cited by 24
Chung, K., Kim, S. W., & Kim, S. W. (2012) · Journal of the Korean Surgical Society · doi:10.4174/jkss.2012.82.5.271 · Cited by 24
Wang, S., Zhao, W., Wang, W., Teng, X., Teng, L., & Ma, Z.-M. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.2.707 · Cited by 18
Genetic and epigenetic alterations in differentiated thyroid carcinoma.
Brehar, A. C., Brehar, F. M., Bulgar, A., & Dumitrache, C. (2013) · PubMed Central · Cited by 17
INCIDENCE OF THYROID MALIGNANCY IN MULTINODULAR GOITER
Ullah, I., Hafeez, M., Ahmad, N., Muahammad, G., & Gandapur, S. (2014) · Journal of Medical Sciences · Cited by 7
Metadata
- Authors
- Abdullah, M. I., Junit, S. M., Ng, K. L., Jayapalan, J. J., Karikalan, B., & Hashim, O. H.
- Venue
- International Journal of Medical Sciences
- Publisher
- Ivyspring International Publisher
- Published
- 2019
- Volume
- 16
- Issue
- 3
- Pages
- 450-460
- ISSN
- 1449-1907 (ISSN-L)
- OpenAlex
- W2922772115
- Cited by
- 337
- References
- 84
- FWCI
- 25.64
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.